Genetic association of interleukin-1β (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians

被引:41
|
作者
Achyut, B. R. [1 ]
Srivastava, Akanksha [1 ]
Bhattacharya, Sandeep [1 ]
Mittal, Balraj [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow 226014, Uttar Pradesh, India
关键词
type; 2; diabetes; proinflammatory cytokines; genetic association; gene polymorphism;
D O I
10.1016/j.cca.2006.09.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Type 2 diabetes mellitus (T2DM) is associated with a subclinical systemic inflammation and development of complications like nephropathy, retinopathy, neuropathy and hypertension. We studied the genetic association of bi-allelic polymorphism (-511C/T) of interleukin (IL)-1 beta and 86 bp variable number tandem repeat (VNTR) polymorphism of natural receptor antagonist (IL-IRN) with T2DM and associated complications in North Indians. Methods: We genotyped 200 patients with T2DM and 223 healthy control subjects for IL-1 beta (-511C/T) by PCR-RFLP. Genotyping of IL-1RN (VNTR) polymorphism was determined by gel electrophoresis after PCR amplification. Results: Interleukin-1 beta (-511C/T) and IL-1RN (VNTR) polymorphisms; were significantly associated with T2DM. IL-1 beta-511T, IL-IRN*2 and IL-IRN*3 alleles were associated with high risk of T2DM whereas; individuals with IL-1 beta-511C and IL-IRN*1 alleles were at low risk. Haplotype frequency analysis showed that T2 (IL-1 beta-511T/IL-1RN*2) haplotype was associated with the high risk (p=0.000; OR=2.4, 95% CI 1.68-3.34) and C1 (IL-1 beta-511C/IL-1RN*1) haplotype showed low risk (p=0.000; OR=0.38, 95% CI 0.27-0.53). Further, CT, TT genotypes of IL-1 beta (-511C/T) and 1/2 genotype of IL-1RN (VNTR) were found to be associated with risk of complications particularly with nephropathy in T2DM. Conclusion: The IL-1 beta (-511C/T) and IL-1RN (VNTR) polymorphisms are significantly associated with increased risk of T2DM as well as associated complications in North Indians. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [31] Association of Interleukin-1 Gene Cluster and Interleukin-1 Receptor Polymorphisms With Febrile Seizures
    Soltani, Samaneh
    Zare-Shahabadi, Ameneh
    Shahrokhi, Amin
    Rezaei, Arezou
    Zoghi, Samaneh
    Zamani, Gholam Reza
    Mohammadi, Mahmoud
    Ashrafi, Mahmoud Reza
    Rezaei, Nima
    JOURNAL OF CHILD NEUROLOGY, 2016, 31 (06) : 673 - 677
  • [32] Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
    Cannon, JG
    Angel, JB
    Abad, LW
    Vannier, E
    Mileno, MD
    Fagioli, L
    Wolff, SM
    Komaroff, AL
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 253 - 261
  • [33] Association of interleukin-1β and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women
    Cauci, Sabina
    Di Santolo, Manuela
    Casabellata, Giorgia
    Ryckman, Kelli
    Williams, Scott M.
    Guaschino, Secondo
    MOLECULAR HUMAN REPRODUCTION, 2007, 13 (04) : 243 - 250
  • [34] EX-VIVO PRODUCTION OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN TYPE-I DIABETES
    NETEA, MG
    HANCU, N
    CUCUIANU, M
    GRIGORESCUSIDO, P
    POPA, L
    POPA, V
    BLOK, WL
    VANDERMEER, JWM
    DIABETOLOGIA, 1994, 37 : A96 - A96
  • [35] Lack of association of genetic polymorphisms in the interleukin-1β, interleukin-1 receptor antagonist, interleukin-4 and interleukin-10 genes with mitral valve prolapse in Taiwan Chinese
    Chou, HT
    Shi, YR
    Hsu, Y
    Tsai, FJ
    JOURNAL OF HEART VALVE DISEASE, 2003, 12 (01): : 38 - 44
  • [36] Evaluation of the Association between Genetic Polymorphism of Interleukin-1 Beta (-511C/T and+3953C/T) and Cervical Cancer Susceptibility
    Pratap, Pushpendra D.
    Raza, Syed Tasleem
    Zaidi, Ghazala
    Kunwar, Shipra
    Eba, Ale
    Rajput, Muneshwar
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [37] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer:: A meta-analysis
    Camargo, M. Constanza
    Mera, Robertino
    Correa, Pelayo
    Peek, Richard M., Jr.
    Fontham, Elizabeth T. H.
    Goodman, Karen J.
    Piazuelo, M. Blanca
    Sicinschi, Liviu
    Zabaleta, Jovanny
    Schneider, Barbara G.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (09) : 1674 - 1687
  • [38] Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
    Larsen, Claus M.
    Faulenbach, Mirjam
    Vaag, Allan
    Ehses, Jan A.
    Donath, Marc Y.
    Mandrup-Poulsen, Thomas
    DIABETES CARE, 2009, 32 (09) : 1663 - 1668
  • [39] Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma
    Abazis-Stamboulieh, Danai
    Oikonomou, Pagona
    Papadoulis, Nikolaos
    Panayiotidis, Panayiotis
    Vrakidou, Efimia
    Tsezou, Aspasia
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2196 - 2203
  • [40] Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus
    Ybarra, J.
    Lehmann, T. N. O.
    Golay, A.
    Juge-Aubry, C. E.
    Roux-Lombard, P.
    Dayer, J. -M.
    Meier, C. A.
    DIABETES & METABOLISM, 2008, 34 (01) : 75 - 81